KCT0001760招募中未知
Population pharmacokinetic and pharmacodynamic modeling of propofol in underweight patients under general anesthesia
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •1. 20 yr < age <65 yr
- •2. BMI (body mass index) < 18.5 (kg/m2)
- •3. Hemoglobin > 9 g/dl
- •4. Patients who signed a written informed consent form
排除标准
- •1-1. Patients with severely impaired respiratory function or respiratory depression status
- •1-2. Patients with convulsive disorders, head injury, shock, a reduced level of consciousness of uncertain origin, intracranial lesions or increased intracranial pressure, or in patients with severe hepatic impairment
- •1-3. Patients who are concurrently taking other CNS depressants that may cause respiratory depression, hypotension, profound sedation or potentially result in coma
- •1-4. Clinically significant impairment of cardiovascular, respiratory and renal function
- •2. Patients with known hypersensitivity to intervention treatments (propofol) or to any of the excipients
- •3. Patients who are considered by the investigator to be unsuitable to participate in the study for any other reason not mentioned in the inclusion and exclusion criteria.
研究者
相似试验
进行中（未招募）
不适用
Population pharmacokinetic and pharmacodynamic modeling of gabapentin in neuropathic pain - Effect of adjuvant pharmacotherapyEUCTR2009-010783-41-SEppsala University
已完成
不适用
Population Pharmacokinetic and Pharmacodynamic Modeling of Freefol-MCT® in Healthy VolunteersKCT0001931Asan Medical Center60
已完成
不适用
Population pharmacokinetics and pharmacodynamics of sorafenib in hepatocellular carcinoma patients with Child Pugh B liver cirrhosisliver cancer1001965410019815hepatocellular carcinomaNL-OMON44524Academisch Medisch Centrum45
已完成
不适用
Study about the relationship between ramosetron dose, plasma concentration and antiemetic effectKCT0001500Asan Medical Center51
招募中
不适用
Population pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin after intravenous administration in pediatric patientsmultidrug resistant gram negative bacteria (MDR GNB)intravenous colistinPopulation pharmacokineticscolistimethate sodium (CMS)colistinintravenouspediatric patientsTCTR20181001003Graduate School, Chiang Mai University60